Covid-19 action. Expansion of vial production to create industrial base capabilities for national defense

Ended Cooperative Agreement Awarded Last action

Award ID
W58P052220003
Recipient
Awarding agency
Obligated
$4,775,757

Award facts

Assistance listing
12.360 Research on Chemical and Biological Defense
Completion date
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Place of performance
Port Chester, NY 10573, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Covid-19 action: the purpose of this modification is to DE-obligate funding to support DOD agreement close out. -$25,999,734
Amendment Covid-19 action: the purpose of this modification is to DE-obligation funding in support of realigning to HHS successor agreement, to be obligated under the new… -$12,000,000
Amendment Covid-19 action: the purpose of this modification is to obligate funding for USG required enhancements for security, as well as administrative updates and… $284,404
Amendment Research on chemical and biological defense $0
Original award $42,491,087

Quick answers

Who received award W58P052220003?

W58P052220003 was awarded to Schott Pharma Usa, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on January 21, 2022.

How much is award W58P052220003 worth?

$4,775,757 has been obligated on W58P052220003.

Which agency awarded W58P052220003?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W58P052220003, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login